These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 19334069

  • 1. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
    Weiner HL.
    Ann Neurol; 2009 Mar; 65(3):239-48. PubMed ID: 19334069
    [Abstract] [Full Text] [Related]

  • 2. The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?
    Pender MP.
    J Clin Neurosci; 2004 Sep; 11(7):689-92. PubMed ID: 15337125
    [Abstract] [Full Text] [Related]

  • 3. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T.
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [Abstract] [Full Text] [Related]

  • 4. Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapy.
    Vaknin-Dembinsky A, Weiner HL.
    J Neurol Sci; 2007 Aug 15; 259(1-2):90-4. PubMed ID: 17521671
    [Abstract] [Full Text] [Related]

  • 5. [Therapy of multiple sclerosis].
    Simó M.
    Neuropsychopharmacol Hung; 2009 Mar 15; 11(1):23-6. PubMed ID: 19731815
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.
    Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L.
    Mult Scler; 2009 May 15; 15(5):644-6. PubMed ID: 19389752
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy of multiple sclerosis.
    Weiner HL, Hafler DA.
    Ann Neurol; 1988 Mar 15; 23(3):211-22. PubMed ID: 3288084
    [Abstract] [Full Text] [Related]

  • 8. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
    Jilek S, Schluep M, Rossetti AO, Guignard L, Le Goff G, Pantaleo G, Du Pasquier RA.
    Clin Immunol; 2007 Apr 15; 123(1):105-13. PubMed ID: 17188575
    [Abstract] [Full Text] [Related]

  • 9. Protecting axons in multiple sclerosis.
    Wilkins A, Scolding N.
    Mult Scler; 2008 Sep 15; 14(8):1013-25. PubMed ID: 18632772
    [Abstract] [Full Text] [Related]

  • 10. The immunopathogenesis of multiple sclerosis.
    Prat E, Martin R.
    J Rehabil Res Dev; 2002 Sep 15; 39(2):187-99. PubMed ID: 12051463
    [Abstract] [Full Text] [Related]

  • 11. Innate and adaptive immune pathways to tolerance.
    Thornton CA, Morgan G.
    Nestle Nutr Workshop Ser Pediatr Program; 2009 Sep 15; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [Abstract] [Full Text] [Related]

  • 12. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS, Weiner HL.
    Nat Rev Drug Discov; 2008 Nov 15; 7(11):909-25. PubMed ID: 18974749
    [Abstract] [Full Text] [Related]

  • 13. Immunopathogenesis of multiple sclerosis.
    Agrawal SM, Yong VW.
    Int Rev Neurobiol; 2007 Nov 15; 79():99-126. PubMed ID: 17531839
    [Abstract] [Full Text] [Related]

  • 14. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP.
    Nat Clin Pract Neurol; 2006 Apr 15; 2(4):201-11. PubMed ID: 16932551
    [Abstract] [Full Text] [Related]

  • 15. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
    Taoufik E, Tseveleki V, Euagelidou M, Emmanouil M, Voulgari-Kokota A, Haralambous S, Probert L.
    Neurodegener Dis; 2008 Apr 15; 5(1):32-7. PubMed ID: 18075273
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease.
    Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Cammarota G, Mirabella M, Attilio Tonali P, Batocchi AP.
    Hum Immunol; 2008 Dec 15; 69(12):837-9. PubMed ID: 18940217
    [Abstract] [Full Text] [Related]

  • 17. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response.
    Karni A, Abraham M, Monsonego A, Cai G, Freeman GJ, Hafler D, Khoury SJ, Weiner HL.
    J Immunol; 2006 Sep 15; 177(6):4196-202. PubMed ID: 16951385
    [Abstract] [Full Text] [Related]

  • 18. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL, Olson JK.
    J Immunol; 2009 Dec 01; 183(11):6971-80. PubMed ID: 19890055
    [Abstract] [Full Text] [Related]

  • 19. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Sellebjerg F, Börnsen L, Khademi M, Krakauer M, Olsson T, Frederiksen JL, Sørensen PS.
    Neurology; 2009 Dec 08; 73(23):2003-10. PubMed ID: 19996075
    [Abstract] [Full Text] [Related]

  • 20. [Multiple sclerosis: a degenerative disease?].
    Confavreux C, Vukusic S.
    Bull Acad Natl Med; 2008 Mar 08; 192(3):483-91; discussion 492-3. PubMed ID: 18819694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.